McManus EJ - Search Results

1

Metabolics risk factors in a New Zealand glioblastoma cohort.

McManus EJ, Frampton C, Tan A, Phillips MCL. McManus EJ, et al. Neurooncol Pract. 2021 Nov 12;9(1):43-49. doi: 10.1093/nop/npab064. eCollection 2022 Feb. Neurooncol Pract. 2021. PMID: 35096403 Free PMC article.

2

Perry syndrome: a case of atypical parkinsonism with confirmed DCTN1 mutation.

McManus EJ, Poke G, Phillips MC, Asztely F. McManus EJ, et al. N Z Med J. 2020 Apr 24;133(1513):116-118. N Z Med J. 2020. PMID: 32325477

3

Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease.

Phillips MCL, Deprez LM, Mortimer GMN, Murtagh DKJ, McCoy S, Mylchreest R, Gilbertson LJ, Clark KM, Simpson PV, McManus EJ, Oh JE, Yadavaraj S, King VM, Pillai A, Romero-Ferrando B, Brinkhuis M, Copeland BM, Samad S, Liao S, Schepel JAC. Phillips MCL, et al. Among authors: mcmanus ej. Alzheimers Res Ther. 2021 Feb 23;13(1):51. doi: 10.1186/s13195-021-00783-x. Alzheimers Res Ther. 2021. PMID: 33622392 Free PMC article. Clinical Trial.

4

Time-Restricted Ketogenic Diet in Huntington's Disease: A Case Study.

Phillips MCL, McManus EJ, Brinkhuis M, Romero-Ferrando B. Phillips MCL, et al. Among authors: mcmanus ej. Front Behav Neurosci. 2022 Jul 29;16:931636. doi: 10.3389/fnbeh.2022.931636. eCollection 2022. Front Behav Neurosci. 2022. PMID: 35967897 Free PMC article.

5

Feasibility and Safety of a Combined Metabolic Strategy in Glioblastoma Multiforme: A Prospective Case Series.

Phillips MCL, Leyden J, McManus EJ, Lowyim DG, Ziad F, Moon BG, Haji Mohd Yasin NAB, Tan A, Thotathil Z, Jameson MB. Phillips MCL, et al. Among authors: mcmanus ej. J Oncol. 2022 Oct 14;2022:4496734. doi: 10.1155/2022/4496734. eCollection 2022. J Oncol. 2022. PMID: 36276276 Free PMC article.

6

Long-term outcome of 200 patients referred to a first seizure clinic.

Mc Manus E, Gilbertson L, Timmings P, Lynch C, Asztely F. Mc Manus E, et al. Acta Neurol Scand. 2021 Feb;143(2):140-145. doi: 10.1111/ane.13340. Epub 2020 Sep 25. Acta Neurol Scand. 2021. PMID: 32885416

7

Extended Interval Dosing Natalizumab and impact on neuropsychological deficits in Relapsing-Remitting Multiple Sclerosis.

McManus EJ, Clark KM, Frampton C, Macniven JAB, Schepel J. McManus EJ, et al. Mult Scler J Exp Transl Clin. 2022 Feb 23;8(1):20552173211070752. doi: 10.1177/20552173211070752. eCollection 2022 Jan-Mar. Mult Scler J Exp Transl Clin. 2022. PMID: 35223079 Free PMC article.

8

Ketogenic diet in drug-resistant epilepsy with encephalopathy.

Mc Manus EJ, Mc Coy S, Lynch CDP, C L Phillips M. Mc Manus EJ, et al. Intern Med J. 2020 Oct;50(10):1291-1292. doi: 10.1111/imj.15015. Intern Med J. 2020. PMID: 33111415 No abstract available.

9

The use of interferon beta in relapsing-remitting multiple sclerosis.

Etheridge LJ, Beverley DW, Ferrie C, McManus E. Etheridge LJ, et al. Arch Dis Child. 2004 Aug;89(8):789-91. doi: 10.1136/adc.2003.040881. Arch Dis Child. 2004. PMID: 15269086 Free PMC article. Review.

10

Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation.

Boyle K, Zhang JG, Nicholson SE, Trounson E, Babon JJ, McManus EJ, Nicola NA, Robb L. Boyle K, et al. Among authors: mcmanus ej. Cell Signal. 2009 Mar;21(3):394-404. doi: 10.1016/j.cellsig.2008.11.002. Epub 2008 Nov 12. Cell Signal. 2009. PMID: 19056487 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters